Back to mobile site

UPDATE: Credit Suisse Downgrades Ironwood Pharmaceuticals (IRWD) to Neutral

November 7, 2018 5:15 AM EST Send to a Friend
(Updated - November 7, 2018 7:56 AM EST)

(updated to add analyst comments)Credit Suisse analyst Vamil Divan downgraded Ironwood ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login